GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress

Mary M. Mullen, Elena Lomonosova, Michael D. Toboni, Alyssa Oplt, Emily Cybulla, Barbara Blachut, Peinan Zhao, Hollie Noia, Daniel Wilke, Erinn B. Rankin, Lindsay M. Kuroki, Andrea R. Hagemann, Ian S. Hagemann, Carolyn K. McCourt, Premal H. Thaker, David G. Mutch, Matthew A. Powell, Nima Mosammaparast, Alessandro Vindigni, Katherine C. Fuh

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress'. Together they form a unique fingerprint.

Medicine & Life Sciences